135 related articles for article (PubMed ID: 23942916)
1. Impact of age cutoffs on a lynch syndrome screening program.
Gudgeon JM; Belnap TW; Williams JL; Williams MS
J Oncol Pract; 2013 Jul; 9(4):175-9. PubMed ID: 23942916
[TBL] [Abstract][Full Text] [Related]
2. Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population.
Cenin DR; Naber SK; Lansdorp-Vogelaar I; Jenkins MA; Buchanan DD; Preen DB; Ee HC; O'Leary P
J Gastroenterol Hepatol; 2018 Oct; 33(10):1737-1744. PubMed ID: 29645364
[TBL] [Abstract][Full Text] [Related]
3. Which Lynch syndrome screening programs could be implemented in the "real world"? A systematic review of economic evaluations.
Di Marco M; DAndrea E; Panic N; Baccolini V; Migliara G; Marzuillo C; De Vito C; Pastorino R; Boccia S; Villari P
Genet Med; 2018 Oct; 20(10):1131-1144. PubMed ID: 29300371
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study.
Li D; Hoodfar E; Jiang SF; Udaltsova N; Pham NP; Jodesty Y; Armstrong MA; Hung YY; Baker RJ; Postlethwaite D; Ladabaum U; Levin TR; Corley DA; Bergoffen J
Ann Intern Med; 2019 Jul; 171(1):19-26. PubMed ID: 31181578
[TBL] [Abstract][Full Text] [Related]
5. Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives.
Salikhanov I; Heinimann K; Chappuis P; Buerki N; Graffeo R; Heinzelmann V; Rabaglio M; Taborelli M; Wieser S; Katapodi MC
J Med Genet; 2022 Sep; 59(9):924-930. PubMed ID: 34782441
[TBL] [Abstract][Full Text] [Related]
6. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.
Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC;
JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.
Chen YE; Kao SS; Chung RH
PLoS One; 2016; 11(8):e0160599. PubMed ID: 27482709
[TBL] [Abstract][Full Text] [Related]
9. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
[TBL] [Abstract][Full Text] [Related]
10. Distinct clinical phenotype and genetic testing strategy for Lynch syndrome in China based on a large colorectal cancer cohort.
Dong L; Jin X; Wang W; Ye Q; Li W; Shi S; Guo L; Ying J; Zou S
Int J Cancer; 2020 Jun; 146(11):3077-3086. PubMed ID: 32030746
[TBL] [Abstract][Full Text] [Related]
11. The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
Kang YJ; Killen J; Caruana M; Simms K; Taylor N; Frayling IM; Snowsill T; Huxley N; Coupe VM; Hughes S; Freeman V; Boussioutas A; Trainer AH; Ward RL; Mitchell G; Macrae FA; Canfell K
Med J Aust; 2020 Feb; 212(2):72-81. PubMed ID: 31595523
[TBL] [Abstract][Full Text] [Related]
12. Implementation of a Systematic Tumor Screening Program for Lynch Syndrome in an Integrated Health Care Setting.
Clarke EV; Muessig KR; Zepp J; Hunter JE; Syngal S; Acheson LS; Wiesner GL; Peterson SK; Bergen KM; Shuster E; Davis JV; Schneider JL; Kauffman TL; Gilmore MJ; Reiss JA; Rope AF; Cook JE; Goddard KAB
Fam Cancer; 2019 Jul; 18(3):317-325. PubMed ID: 30729418
[TBL] [Abstract][Full Text] [Related]
13. Population-Based Lynch Syndrome Screening by Microsatellite Instability in Patients ≤50: Prevalence, Testing Determinants, and Result Availability Prior to Colon Surgery.
Karlitz JJ; Hsieh MC; Liu Y; Blanton C; Schmidt B; Jessup JM; Wu XC; Chen VW
Am J Gastroenterol; 2015 Jul; 110(7):948-55. PubMed ID: 25601013
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of genetic diagnostic strategies for Lynch syndrome in Italy.
Pastorino R; Basile M; Tognetto A; Di Marco M; Grossi A; Lucci-Cordisco E; Scaldaferri F; De Censi A; Federici A; Villari P; Genuardi M; Ricciardi W; Boccia S
PLoS One; 2020; 15(7):e0235038. PubMed ID: 32609729
[TBL] [Abstract][Full Text] [Related]
15. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
Schofield L; Goldblatt J; Iacopetta B
Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of screening strategies for Lynch syndrome.
Barzi A; Sadeghi S; Kattan MW; Meropol NJ
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794514
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age.
Goverde A; Spaander MC; van Doorn HC; Dubbink HJ; van den Ouweland AM; Tops CM; Kooi SG; de Waard J; Hoedemaeker RF; Bruno MJ; Hofstra RM; de Bekker-Grob EW; Dinjens WN; Steyerberg EW; Wagner A;
Gynecol Oncol; 2016 Dec; 143(3):453-459. PubMed ID: 27789085
[TBL] [Abstract][Full Text] [Related]
18. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.
Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B
Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016
[TBL] [Abstract][Full Text] [Related]
19. Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives.
Hunter JE; Arnold KA; Cook JE; Zepp J; Gilmore MJ; Rope AF; Davis JV; Bergen KM; Esterberg E; Muessig KR; Peterson SK; Syngal S; Acheson L; Wiesner G; Reiss J; Goddard KAB
Fam Cancer; 2017 Jul; 16(3):377-387. PubMed ID: 28176204
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent performance of BRAF mutation testing in Lynch syndrome diagnostics.
Bläker H; Haupt S; Morak M; Holinski-Feder E; Arnold A; Horst D; Sieber-Frank J; Seidler F; von Winterfeld M; Alwers E; Chang-Claude J; Brenner H; Roth W; Engel C; Löffler M; Möslein G; Schackert HK; Weitz J; Perne C; Aretz S; Hüneburg R; Schmiegel W; Vangala D; Rahner N; Steinke-Lange V; Heuveline V; von Knebel Doeberitz M; Ahadova A; Hoffmeister M; Kloor M;
Int J Cancer; 2020 Nov; 147(10):2801-2810. PubMed ID: 32875553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
